Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Cash Flow Reinvestment Rate
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow Reinvestment Rate of 0.24x as of September 2025, reinvesting CN¥5.45 Million (capex CN¥5.45 Million ) from operating cash flow of CN¥22.69 Million. Explore Henan Taloph Pharmaceutical Stock Co Ltd (600222) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Henan Taloph Pharmaceutical Stock Co Ltd across 24 annual periods. Also explore 600222 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Henan Taloph Pharmaceutical Stock Co Ltd. For live market cap and broader valuation context, see 600222 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.90x | CN¥42.25 Million | CN¥47.16 Million | CN¥21.12 Million | ▼ -74.2% |
| 2023 | 3.48x | CN¥152.04 Million | CN¥43.74 Million | CN¥43.13 Million | ▲ +173.3% |
| 2021 | 1.27x | CN¥126.74 Million | CN¥99.66 Million | CN¥39.07 Million | ▼ -51.6% |
| 2020 | 2.63x | CN¥192.82 Million | CN¥73.43 Million | CN¥72.65 Million | ▼ -31.7% |
| 2019 | 3.84x | CN¥159.55 Million | CN¥41.53 Million | CN¥107.68 Million | ▲ +378.1% |
| 2018 | 0.80x | CN¥96.01 Million | CN¥119.47 Million | CN¥66.41 Million | ▼ -87.2% |
| 2017 | 6.27x | CN¥145.19 Million | CN¥23.17 Million | CN¥44.34 Million | ▲ +484.4% |
| 2016 | 1.07x | CN¥75.70 Million | CN¥70.60 Million | CN¥59.60 Million | ▼ -48.6% |
| 2015 | 2.08x | CN¥102.71 Million | CN¥49.27 Million | CN¥62.04 Million | ▲ +424.0% |
| 2014 | 0.40x | CN¥35.62 Million | CN¥89.54 Million | CN¥35.62 Million | ▲ +133.4% |
| 2012 | 0.17x | CN¥14.91 Million | CN¥87.45 Million | CN¥14.91 Million | ▼ -100.0% |
| 2011 | 612.28x | CN¥64.41 Million | CN¥105.20K | CN¥64.41 Million | ▲ +46377.1% |
| 2009 | 1.32x | CN¥28.25 Million | CN¥21.45 Million | CN¥28.25 Million | ▼ -41.7% |
| 2008 | 2.26x | CN¥40.98 Million | CN¥18.13 Million | CN¥40.98 Million | ▲ +13.7% |
| 2007 | 1.99x | CN¥42.42 Million | CN¥21.34 Million | CN¥42.42 Million | ▼ -91.4% |
| 2006 | 22.99x | CN¥36.64 Million | CN¥1.59 Million | CN¥36.64 Million | ▼ -69.0% |
| 2005 | 74.04x | CN¥20.46 Million | CN¥276.30K | CN¥20.46 Million | ▲ +8971.7% |
| 2004 | 0.82x | CN¥14.90 Million | CN¥18.25 Million | CN¥14.90 Million | ▼ -81.9% |
| 2003 | 4.52x | CN¥16.89 Million | CN¥3.74 Million | CN¥16.89 Million | ▲ +430.5% |
| 2002 | 0.85x | CN¥6.36 Million | CN¥7.47 Million | CN¥6.36 Million | ▼ -20.2% |
| 2001 | 1.07x | CN¥58.73 Million | CN¥55.03 Million | CN¥58.73 Million | ▼ -99.1% |
| 2000 | 123.50x | CN¥108.11 Million | CN¥875.36K | CN¥108.11 Million | ▲ +15260.6% |
| 1999 | 0.80x | CN¥79.86 Million | CN¥99.32 Million | CN¥79.86 Million | ▲ +63076.1% |
| 1998 | 0.00x | CN¥35.69K | CN¥28.04 Million | CN¥35.69K | — |